Cargando…
HER2 status in advanced gastric carcinoma: A retrospective multicentric analysis from Sicily
According to the ToGA trial, HER2 has been shown to be predictive for the success of treatment with trastuzumab in advanced gastric cancer (AGC). A number of studies have analyzed HER-2/neu overexpression in gastric carcinoma and identified the rate of HER2 positivity to be markedly varied. To date,...
Autores principales: | IENI, A., BARRESI, V., GIUFFRÈ, G., CARUSO, R.A., LANZAFAME, S., VILLARI, L., SALOMONE, E., ROZ, E., CABIBI, D., FRANCO, V., CERTO, G., LABATE, A., NAGAR, C., MAGLIOLO, E., BROGGI, B., FAZZARI, C., ITALIA, F., TUCCARI, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833944/ https://www.ncbi.nlm.nih.gov/pubmed/24260051 http://dx.doi.org/10.3892/ol.2013.1611 |
Ejemplares similares
-
HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach
por: Ieni, A., et al.
Publicado: (2015) -
Immunoexpression of lactoferrin in bone metastases and corresponding primary carcinomas
por: IENI, A., et al.
Publicado: (2013) -
Discordance rate of HER2 status in primary breast carcinomas versus synchronous axillary lymph node metastases: a multicenter retrospective investigation
por: Ieni, Antonio, et al.
Publicado: (2014) -
Discordance Rate of HER2 Status in Primary Gastric Carcinomas and Synchronous Lymph Node Metastases: A Multicenter Retrospective Analysis
por: Ieni, Antonio, et al.
Publicado: (2014) -
Human Epidermal Growth Factor Receptor 2 Status in Gastric Carcinomas with Distinctive Prevalent Cribriform Component
por: Ieni, Antonio, et al.
Publicado: (2018)